SEPTInvestingStart Free

RCKT 10-Q: SEC filing

Rocket Pharmaceuticals

Filed with the SEC on · accession 0001193125-26-458320

RCKT filed a 10-Q (quarterly report) with the SEC on Nov 12, 2026. Rocket Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including expenses, loan agreements, and equity activity. The stock moved -3.6% by the first close after the filing.

Summary of the filing

Rocket Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including expenses, loan agreements, and equity activity. No single material corporate event is identifiable from the filing text.

For details, click here →How to read a 10-Q →

Key details

FilerRocket Pharmaceuticals, Inc.
At-the-market offering agentCantor Fitzgerald & Co.
LenderHercules
Acquired subsidiaryRenovacor, Inc.

How RCKT stock reacted

Close before

$2.48

Nov 11, 2026

First close after

-3.63%

$2.39

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for RCKT, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RCKT?

Click here

Frequently asked questions

What did RCKT file with the SEC on Nov 12, 2026?

RCKT filed a 10-Q (SEC filing). Rocket Pharmaceuticals filed its quarterly 10-Q report for the period ending September 30, 2026, disclosing routine financial results including expenses, loan agreements, and equity activity. No single material corporate event is identifiable from the filing text.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did RCKT stock react to this filing?

RCKT closed at $2.48 before the filing and $2.39 on Nov 12, 2026 (-3.63%).

Other RCKT SEC filings

Get alerts when RCKT files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
RCKT overviewRCKT analysisRCKT newsLatest SEC filings